Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms.


Creative Commons License

Köker I. H. , Ünver N., Malya F. Ü. , Uysal Ö. , Keskin E. , Şentürk H.

Clinical endoscopy, vol.54, pp.113-121, 2021 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 54
  • Publication Date: 2021
  • Doi Number: 10.5946/ce.2020.083
  • Title of Journal : Clinical endoscopy
  • Page Numbers: pp.113-121
  • Keywords: Carcinoembryonic antigen, Malignancy, Pancreatic cysts, INTERNATIONAL CONSENSUS GUIDELINES, PANCREATIC CYSTS, DIAGNOSIS, MANAGEMENT, CEA, CLASSIFICATION, COMBINATION, PERFORMANCE, ACCURACY, FEATURES

Abstract

Background/Aims: The role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating mucinous pancreatic cystic lesions (PCLs) is controversial. We investigated the role of cyst fluid CEA in differentiating low-risk (LR)-intraductal papillary mucinous neoplasms (IPMNs) from high-risk (HR)-IPMNs and LR-mucinous cystic neoplasms (MCNs).